DOES GENETIC SUSCEPTIBILITY TESTING FOR ALZHEIMER’S DISEASE AFFECT INSURANCE CHOICES AMONG AT RISK FIRST DEGREE RELATIVES?
Dapo Akinleye

COMBINATION THERAPY USING MINOCYCLINE AND COENZYME Q10 IN R6/2 TRANSGENIC HD MICE.
Robert Ferrante Ph.D.

COMPARISON OF LANGUAGE SKILLS IN PROBANDS WITH AUTISM AND SPECIFIC LANGUAGE IMPAIRMENT.
Kristen A. Lindgren, Susan E. Folstein M.D., J. Bruce Tomblin Ph.D., Helen Tager-Flusberg Ph.D.

HIGH FREQUENCY ACTIVITY IN THE SUBSTANTIA NIGRA AND THE SUBTHALAMIC NUCLEUS IN PARKINSON’S DISEASE.
Peter Novak M.D., Jules Nazarro M.D., Samuel Ellias M.D., Melissa Diggin, Slawomir Dalinuk

MAGNETIC RESONANCE MICROSCOPY OF RED AND WHITE THROMBI.
Jason Viereck M.D.

INTERACTIONS OF THE PREFRONTAL CORTEX AND MEDIAL TEMPORAL LOBE IN DELAYED NON-MATCHING TO SAMPLE (DNMS).
Laura Welke, Tara L. Moore Ph.D., Ronald J. Killiany Ph.D., Douglas L. Rosene Ph.D., Mark B. Moss Ph.D.

SELECTIVE INACTIVATION OR RECONSTITUTION OF ADENOSINE A2A RECEPTORS IN BONE MARROW CELLS REVEALS THEIR CRITICAL ROLE IN THE DEVELOPMENT OF ISCHEMIC BRAIN INJURY.
Liqun Yu M.D., Ph.D., Ahihong Huang, Juliana Mariani, Yumei Wang, Michael Moskowitz, Jiang-Fan Chen M.D., Ph.D.

TRANSCRIPTIONAL REGULATORY NETWORK VIA EGR2 IN STRIATUM BY GENETIC AND PHARMACOLOGICAL INACTIVATION OF THE ADENOSINE A2A RECEPTOR AS REVEALED BY MICROARRAY AND BIOINFORMATICS ANALYSES.
Liqun Yu M.D., Ph.D., Peter Haverty, Juliana Mariani, Michael A. Schwarzschild M.D., Ph.D., Zhiping Weng, Jiang-Fan Chen M.D., Ph.D.

 

RETURN TO MAIN PAGE